Smiths Medical voluntarily withdraws blood glucose monitors

Smiths Medical is pulling a line of blood glucose monitors from the market because supplies of compatible test strips have run out and no alternatives exist.

The St. Paul, Minn.-based company said March 30 that only its CoZmonitor systems are affected. It also said the FDA has been notified along with customers.  

Smiths Medical is a division of the Smiths Group, a multinational based in the U.K.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.